Although we could see a clear trend toward more pronounced LV dysfunction and higher NT-proBNP levels in MWF+ patients, a larger patient cohort may be needed to demonstrate statistically significant differences between MWF– and MWF+ patients with regard to clinical and functional markers of heart failure. Here, NPPB is linked to heart failure.